Capmatinib in patients with high-level MET-amplified advanced non-small cell lung cancer (NSCLC): results from the phase 2 GEOMETRY mono-1 study.

Wolf, J., Overbeck, T. R., Han, J-Y., Hochmair, M., de Marinis, F., Ohashi, K., Smit, E. F., Power, D., Garon, E. B., Groen, H. J. M., Tan, D. S-W., Waldron-Lynch, M., Le Mouhaer, S., Nwana, N., Giovannini, M. & Heist, R. S., 20-May-2020, In : Journal of Clinical Oncology. 38, 15, 2 p.

Research output: Contribution to journalMeeting AbstractAcademic

  • Juergen Wolf
  • Tobias R. Overbeck
  • Ji-Youn Han
  • Maximilian Hochmair
  • Filippo de Marinis
  • Kadoaki Ohashi
  • Egbert F. Smit
  • Danielle Power
  • Edward B. Garon
  • Harry J. M. Groen
  • Daniel Shao-Weng Tan
  • Maeve Waldron-Lynch
  • Sylvie Le Mouhaer
  • Ngozi Nwana
  • Monica Giovannini
  • Rebecca Suk Heist
Original languageEnglish
Number of pages2
JournalJournal of Clinical Oncology
Issue number15
Publication statusPublished - 20-May-2020

ID: 136156329